Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of GBP 240.63 billion. The enterprise value is 259.28 billion.

Market Cap	240.63B
Enterprise Value	259.28B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Mar 11, 2025

Share Statistics

Current Share Class	1.91B
Shares Outstanding	n/a
Shares Change (YoY)	-3.93%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	37.45%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 23.16 and the forward PE ratio is 19.11.

PE Ratio	23.16
Forward PE	19.11
PS Ratio	5.71
PB Ratio	6.96
P/TBV Ratio	n/a
P/FCF Ratio	18.41
P/OCF Ratio	16.92
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.26, with an EV/FCF ratio of 19.83.

EV / Earnings	24.95
EV / Sales	5.97
EV / EBITDA	14.26
EV / EBIT	17.82
EV / FCF	19.83

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.76.

Current Ratio	1.12
Quick Ratio	0.82
Debt / Equity	0.76
Debt / EBITDA	1.49
Debt / FCF	2.02
Interest Coverage	16.61

Financial Efficiency

Return on equity (ROE) is 30.81% and return on invested capital (ROIC) is 23.60%.

Return on Equity (ROE)	30.81%
Return on Assets (ROA)	11.14%
Return on Invested Capital (ROIC)	23.60%
Return on Capital Employed (ROCE)	22.71%
Weighted Average Cost of Capital (WACC)	6.37%
Revenue Per Employee	559,459
Profits Per Employee	138,043
Employee Count	75,267
Asset Turnover	0.53
Inventory Turnover	2.27

Taxes

In the past 12 months, Novartis AG has paid 1.77 billion in taxes.

Income Tax	1.77B
Effective Tax Rate	14.59%

Stock Price Statistics

The stock price has increased by +33.73% in the last 52 weeks. The beta is 0.46, so Novartis AG's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+33.73%
50-Day Moving Average	117.20
200-Day Moving Average	103.78
Relative Strength Index (RSI)	73.39
Average Volume (20 Days)	1,904,722

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of GBP 42.11 billion and earned 10.39 billion in profits. Earnings per share was 5.31.

Revenue	42.11B
Gross Profit	31.99B
Operating Income	14.12B
Pretax Income	12.15B
Net Income	10.39B
EBITDA	17.44B
EBIT	14.12B
Earnings Per Share (EPS)	5.31

Full Income Statement

Balance Sheet

The company has 8.57 billion in cash and 26.34 billion in debt, giving a net cash position of -17.78 billion.

Cash & Cash Equivalents	8.57B
Total Debt	26.34B
Net Cash	-17.78B
Net Cash Per Share	n/a
Equity (Book Value)	34.59B
Book Value Per Share	17.96
Working Capital	2.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.22 billion and capital expenditures -1.15 billion, giving a free cash flow of 13.07 billion.

Operating Cash Flow	14.22B
Capital Expenditures	-1.15B
Free Cash Flow	13.07B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.97%, with operating and profit margins of 33.53% and 24.67%.

Gross Margin	75.97%
Operating Margin	33.53%
Pretax Margin	28.85%
Profit Margin	24.67%
EBITDA Margin	41.42%
EBIT Margin	33.53%
FCF Margin	31.05%

Dividends & Yields

This stock pays an annual dividend of 3.07, which amounts to a dividend yield of 2.36%.

Dividend Per Share	3.07
Dividend Yield	2.36%
Dividend Growth (YoY)	4.54%
Years of Dividend Growth	4
Payout Ratio	55.91%
Buyback Yield	3.93%
Shareholder Yield	6.29%
Earnings Yield	4.32%
FCF Yield	5.43%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.81 and a Piotroski F-Score of 7.

Altman Z-Score	3.81
Piotroski F-Score	7